VisAbility Micro Insert System for Presbyopia
Official title: A Prospective, Multicenter Clinical Trial To Evaluate The Safety And The Improvement In Near Visual Acuity In Presbyopic Patients Treated With The VisAbility™ Micro Insert System Through 12 Months
Run by VisDura, Inc. · NCT07637500 · Data updated 2026-11-12
A new device called the VisAbility Micro Insert System is being tested to see if it can improve near vision at reading distance for adults with presbyopia.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 45 Years to 60 Years |
| Sex | All |
| Enrollment | 33 (estimated) |
| Sponsor | VisDura, Inc. Industry-sponsored |
| Locations | 2 sites (Bochum and 1 other locations) |
| Status | Recruiting |
| Started | June 2, 2026 |
| Main results expected | December 2027 |
| Study ends | December 2027 |
| Registry record updated | October 15, 2026 |
| Trial ID | NCT07637500 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 45–60 with 20/20 distance vision in both eyes and poor near vision at 40 cm in both eyes.
✕Probably not a fit
Individuals with ocular inflammation, inflammatory eye disease, autoimmune conditions, or significant iris/pupillary differences may not benefit and could be excluded.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study evaluates the VisAbility Micro Insert System in presbyopic adults. Eligible participants are 45 to 60 years old with perfect distance vision in both eyes and reduced near vision at 40 cm. The trial focuses on safety and the ability of the device to improve binocular distance-corrected near visual acuity. No phase information is provided. It is conducted at two European eye centers with VisDura, Inc. as the sponsor.
Why it matters
Potential benefit: If successful, participants may experience better clarity at near reading distances with improved binocular near vision.
How similar studies have gone: Previous similar approaches in vision correction have shown mixed results; this specific device trial is a novel application awaiting outcomes.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Subjects must be between ages of 45 to 60 at the time of enrolment. 2. Subjects must have best corrected distance visual acuity (BCDVA) of 20/20 in each eye. 3. Subjects must have distance corrected near visual acuity (DCNVA) @ 40 cm of 20/50, 20/63 or 20/80 in each eye. 4. Subjects must have binocular distance corrected near visual acuity (DCNVA) @ 40 cm of 20/50, 20/63 or 20/80. Exclusion Criteria: 1. Subjects where either pupil has a baseline percent change from scotopic to photopic of less than 30% or an absolute difference of less than 1.00 mm between scotopic and photopic pupil size as measured by the NeurOptics Pupillometer. 2. Subjects with ocular inflammation, chronic uveitis, or other recurrent anterior or posterior segment inflammatory conditions in either eye; subjects with any ocular or systemic disease(s) posting a significant risk for ocular inflammation, including but not limited to autoimmune disorders (e.g., rheumatoid arthritis, ankylosing spondylitis, Reiter's syndrome, ulcerative colitis, Crohn's disease, psoriasis, sarcoidosis, Behcet's disease), infections (toxoplasmosis, cat-scratch fe ver, West Nile virus, syphilis, tuberculosis, herpes zoster, herpes simplex, adenovirus), ocular trauma, or gout. 3. Subjects with scleral thickness of less than 530 microns as measured 3.5 to 4.0 mm posterior to the superior temporal quadrant limbus in either eye. 4. Subjects with a history of any prior intraocular procedure (e.g., corneal transplant, filtering procedures for glaucoma, vitrectomy, retinal detachment repair, cataract surgery) or any prior refractive procedure (e.g. LASIK, surface excimer, or incisional surgery) in either eye.
Where it's running
-
Ruhr University Eye Hospital
Bochum, Germany Recruiting -
Universitäts-Augenklinik Heidelberg
Heidelberg, Germany Recruiting
Study contacts
- Study coordinator: Safia Ayachi
- Email: safia@medevise-consulting.com
- Phone: +3388308811
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
See if the Morrow eProgressive lenses work better than standard PALs for presbyopia
This study tests whether the electronically adjustable Morrow eProgressive lenses help people with presbyopia see and move more naturally compared with traditional progressive lenses.
-
Volumetric visual fields with occupational vs general-purpose progressive lenses in presbyopia
This study tests whether two occupational progressive lenses and a general-purpose PAL give different depth of clear vision at multiple distances for people with presbyopia.
-
Trying DAILIES TOTAL1 Multifocal Lenses in satisfied INFUSE wearers
This study tests whether switching satisfied INFUSE One-Day Multifocal wearers to DAILIES TOTAL1 Multifocal lenses maintains comfort and clear vision.
-
Volumetric visual fields with progressive lenses for presbyopia at intermediate and near distances
Researchers will test two occupational progressive lenses to see which provides a larger clear field at intermediate and near distances for people with presbyopia.
-
Total30 Multifocal Toric Contact Lenses in Presbyopic Toric Wearers
This study tests whether Total30 MFT toric contact lenses are comfortable and acceptable for people who already wear reusable toric lenses and are now presbyopic.
-
A Smart Aperture Lens to Help Keratoconus and Presbyopia
This study tests the NOA lens, a custom scleral contact lens with a central aperture, to see if it improves vision for people with keratoconus and presbyopia.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.